172 related articles for article (PubMed ID: 7466305)
1. A critical review of platelet yield by Haemonetics 30 . Based on literature and own observations.
Rosenkvist J; Holsøe E; Freiesleben E; Sørensen H
Scand J Haematol; 1980 Aug; 25(2):165-70. PubMed ID: 7466305
[TBL] [Abstract][Full Text] [Related]
2. Comparison of plateletpheresis on the Fresenius AS.TEC 204 and Haemonetics MCS 3p.
Ranganathan S
J Clin Apher; 2007 Feb; 22(1):1-4. PubMed ID: 17111420
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing yield of plateletpheresis using intermittent flow cell separator.
DAS SS; Chaudhary RK; Shukla JS
Clin Lab Haematol; 2005 Oct; 27(5):316-9. PubMed ID: 16178912
[TBL] [Abstract][Full Text] [Related]
4. [Efficiency of the blood cell separator Haemonetic 30 in the separation of platelets from single donors].
Gmür J; Hirvonen H; Fehr J; Honegger HP
Schweiz Med Wochenschr; 1977 Oct; 107(41):1452-3. PubMed ID: 918594
[TBL] [Abstract][Full Text] [Related]
5. [The influence of initial values of donor platelets count on the efficiency of plateletpheresis with the cell separator Fenval Baxter Amicus s.v.2.51].
Landzo E; Berbić-Fazlagić J; Sofo-Hafizović A
Med Arh; 2009; 63(2):67-70. PubMed ID: 19537658
[TBL] [Abstract][Full Text] [Related]
6. Donor platelet response and product quality assurance in plateletpheresis.
Lasky LC; Lin A; Kahn RA; McCullough J
Transfusion; 1981; 21(3):247-60. PubMed ID: 7233509
[TBL] [Abstract][Full Text] [Related]
7. Optimization of platelet concentrate collection for continuous flow cell separation devices (CFCS).
Hester JP; Ventura J
Ann Med Interne (Paris); 1988; 139 Suppl 1():7-10. PubMed ID: 3247996
[TBL] [Abstract][Full Text] [Related]
8. Effect of donor variables on yield in single donor plateletpheresis by continuous flow cell separator.
Chaudhary R; Das SS; Khetan D; Sinha P
Transfus Apher Sci; 2006 Apr; 34(2):157-61. PubMed ID: 16510315
[TBL] [Abstract][Full Text] [Related]
9. [A new separation protocol (DRBCP-F) for automated blood component donation with the MCS 3p cell separator for collection of leukocyte depleted erythrocyte concentrates and plasma].
Zeiler T; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1997; 34():118-22. PubMed ID: 9417335
[TBL] [Abstract][Full Text] [Related]
10. [Study of the platelet concentrate obtained with the MCS cell separator of the Society of Haemonetics].
Schooneman F
Ann Med Interne (Paris); 1994; 145(5):345-9. PubMed ID: 7985946
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of plateletpheresis using Baxter CS 3000 plus and Haemonetics MCS 3P.
Patel AP; Kaur A; Patel V; Patel N; Shah D; Kanvinde S; Prajapati S; Patel H; Rathod D; Adesara R; Rani S
J Clin Apher; 2004; 19(3):137-41. PubMed ID: 15493051
[TBL] [Abstract][Full Text] [Related]
12. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL.
Alex J; Roberts B; Raife T
J Clin Apher; 2009; 24(5):215-7. PubMed ID: 19816960
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the performance of Trima Accel® v5.2 for the collection of concentrated high-dose platelet products and concurrent plasma from high platelet count donors, in Germany.
Daskalakis M; Schulz-Huotari C; Burger M; Klink I; Umhau M
J Clin Apher; 2012; 27(2):75-80. PubMed ID: 22362609
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
[TBL] [Abstract][Full Text] [Related]
15. Fuji surge technique and continuous in-line filtration to improve the quality of single donor platelet concentrates.
Moog R
J Clin Apher; 2002; 17(4):199-203. PubMed ID: 12494413
[TBL] [Abstract][Full Text] [Related]
16. [Technical aspects of extraction of platelet concentrates from dogs with an automated cell separator].
Adamik A; Klein A; Mischke R
Dtsch Tierarztl Wochenschr; 1997 Dec; 104(12):523-6. PubMed ID: 9451860
[TBL] [Abstract][Full Text] [Related]
17. [Haemonetics MCS-3 pump system: improved production quality in thrombocytapheresis with a discontinuous cell separator].
Pawlow I; Richter E; Matthes G; Rath E; Tofoté U
Beitr Infusionsther Transfusionsmed; 1994; 32():325-7. PubMed ID: 9480119
[TBL] [Abstract][Full Text] [Related]
18. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
Tondon R; Pandey P; Chaudhry R
J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the haemonetics MCS cell separator in the collection of apheresis platelets.
Keklik M; Keklik E; Korkmaz S; Aygun B; Arik F; Kilic O; Sarikoc M
Transfus Apher Sci; 2015 Dec; 53(3):396-8. PubMed ID: 26283175
[TBL] [Abstract][Full Text] [Related]
20. The influence of CS-3000 plateletapheresis on blood donors and on platelet concentrates.
Kotelba-Witkowska B; Mrowiec ZR; Daszyński J; Skrzeczkowska E; Stachecki B; Kaszkowiak M; Jakuboszczak E
Mater Med Pol; 1990; 22(1):29-32. PubMed ID: 2079857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
